Pat | Age | Sex | SSA medication | Time (d) between SSA and 68Ga-DOTATOC PET/CT Baseline | Time (d) between SSA and 68Ga-DOTATOC-PET/CT Study | Tumor burden* |
---|---|---|---|---|---|---|
1 | 74 | M | Sandostatin LAR 30 mg/3 w | 17 | 17 | Liver mets 20–25% |
2 | 73 | F | Santostatin Autogel 120 mg /2 w | 14 | 13 | Liver mets < 5% lgll. mets, bone mets, |
3 | 61 | M | Santostatin Autogel /120 mg 2 w | 7 | 6 | Liver mets 20–25% |
4 | 68 | M | Santostatin Autogel 120 mg /4 w | 27 | 25 | Liver mets 20–25% |